Europe Genome Sequencing Market

2.1    Patent Analysis
         2.1.1    Patent Analysis (by Year)
         2.1.2    Patent Analysis (by Country)
2.2    Competitive Benchmarking
         2.2.1    Market Share
         2.2.2    Brand Recognition
2.3    Sequencing Clinical Adoption
2.4    Future Outlook

3.1    Regional Summary
3.2    Drivers and Restraints
3.3    Europe
         3.3.1    Regional Overview
         3.3.2    Driving Factors for Market Growth
         3.3.3    Factors Challenging the Market
         3.3.4    By Product
         3.3.5    By End User
         3.3.6    Germany
                  3.3.6.1    By Product
         3.3.7    U.K.
                  3.3.7.1    By Product
         3.3.8    Spain
                  3.3.8.1    By Product
         3.3.9    Italy
                  3.3.9.1    By Product
         3.3.10    France
                  3.3.10.1    By Product
         3.3.11    Rest-of-Europe
                  3.3.11.1    By Product

4.1    Key Strategies and Development
         4.1.1    Partnerships, Alliances, and Business Expansions
         4.1.2    Regulatory and Legal Activities
         4.1.3    New Offerings
         4.1.4    Mergers and Acquisitions
         4.1.5    Funding Activities
4.2    Company Profiles
         4.2.1    Eurofins Scientific S.E.
                  4.2.1.1    Overview
                  4.2.1.2    Top Products and Services
                  4.2.1.3    Top Competitors
                  4.2.1.4    Key Personnel
                  4.2.1.5    Analyst View
         4.2.2    F. Hoffmann-La Roche Ltd.
                  4.2.2.1    Overview
                  4.2.2.2    Top Products and Services
                  4.2.2.3    Top Competitors
                  4.2.2.4    Key Personnel
                  4.2.2.5    Analyst View
         4.2.3    OncoDNA
                  4.2.3.1    Overview
                  4.2.3.2    Top Products and Services
                  4.2.3.3    Top Competitors
                  4.2.3.4    Key Personnel
                  4.2.3.5    Analyst View
         4.2.4    Oxford Nanopore Technologies plc
                  4.2.4.1    Overview
                  4.2.4.2    Top Products and Services
                  4.2.4.3    Top Competitors
                  4.2.4.4    Key Personnel
                  4.2.4.5    Analyst View
     4.2.5    QIAGEN N.V.
                  4.2.5.1    Overview
                  4.2.5.2    Top Products and Services
                  4.2.5.3    Top Competitors
                  4.2.5.4    Key Personnel
                  4.2.5.5    Analyst View

5.1    Data Sources
         5.1.1    Primary Data Sources
         5.1.2    Secondary Data Sources
         5.1.3    Data Triangulation

Table 1:    Market Snapshot
Table 2:    Genome Sequencing Market, Market Opportunities
Table 3:    Current and Future Impact of Trends
Table 4:    Regulatory Landscape (by Country)
Table 5:    Comparison of Some of the Key Sequencers
Table 6:    Genome Sequencing Market (by Region), $Billion, 2023-2033
Table 7:    Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 8:    Canada Genome Sequencing Market (by End User), $Billion, 2023-2033
Table 9:    Germany Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 10:    U.K. Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 11:    Spain Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 12:    Italy Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 13:    France Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 14:    Rest-of-Europe Genome Sequencing Market, $Billion, 2023-2033
Table 15:    Rest-of-Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
Table 16:    Europe Genome Sequencing Market, Key Development Analysis, January 2020-April 2024

Figure 1:    Europe Genome Sequencing Market, $Billion, 2024, 2028, and 2033
Figure 2:    Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
Figure 3:    Europe Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
Figure 4:    Europe Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
Figure 5:    Key Players’ Strategic Priorities
Figure 6:    Potential Future Directions
Figure 7:    Companies Utilizing Artificial Intelligence in Genomics
Figure 8:    Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
Figure 9:    Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
Figure 10:    Value and Supply Chain Analysis, Genome Sequencing Market
Figure 11:    Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
Figure 12:    Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
Figure 13:    Europe Genome Sequencing Market, Market Share, 2023
Figure 14:    Clinical Utility of Genome Sequencing
Figure 15:    Future Outlook for Genome Sequencing
Figure 16:    Germany Genome Sequencing Market, $Billion, 2023-2033
Figure 17:    U.K. Genome Sequencing Market, $Billion, 2023-2033
Figure 18:    Spain Genome Sequencing Market, $Billion, 2022-2023
Figure 19:    Italy Genome Sequencing Market, $Billion, 2023-2033
Figure 20:    France Genome Sequencing Market, $Billion, 2023-2033
Figure 21:    Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
Figure 22:    Regulatory and Legal Activities, January 2020-April 2024
Figure 23:    New Offerings, January 2020-April 2024
Figure 24:    Mergers and Acquisitions, January 2020-April 2024
Figure 25:    Funding Activities, January 2020-April 2024
Figure 26:    Data Triangulation
Figure 27:    Assumptions and Limitations